Latest News

Image description

Superior front-end experience, improved patient outcomes will define Rite Aid's success

Revising year-end guidance on account of reimbursement rate headwinds, Rite Aid's stock took a hit after reporting second-quarter earnings even though the company beat analysts' consensus estimates for the quarter. The retail pharmacy operation recorded second-quarter profit of $127.8 million, or 13 cents per share, more than doubling FactSet consensus analyst estimate of 6 cents a share, according to a MarketWatch report. And while revenue of $6.5 billion was in line with analyst expectations, Rite Aid topped expected same-store sales growth of 3.3% by recording 4.1% in same-store sales growth. 
 
Rite Aid is still on the right track. 

Image description

NACDS endorses Senate bill to curb Rx abuse

The National Association of Chain Drug Stores has offered its support for new legislation — S. 2862, the Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 — which calls for a collaborative, coordinated approach to curbing prescription drug abuse and safeguarding patients.